Citius Pharmaceuticals, Inc.

CTXR

Citius Pharmaceuticals, Inc.

CTXR

Insider Sentiment (TTM):

Last Purchase:2019-09-27Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:936,128Shares Outstanding:22,376,427Institutional Ownership Pct.:4.18%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	17	5	8	4	6	0	1	3	18	13	20	26
Accounts Receivable Net Current	1	1	4	-	-	-	-	-	-	-	-	-
Inventory Net	23	23	23	22	17	15	14	8	-	-	-	-
Prepaid Expense Current	3	3	4	1	1	3	3	3	10	9	8	8
Inventory Gross	-	-	-	-	-	-	-	8	-	-	-	-
Assets Current	43	32	38	28	25	18	18	14	28	22	28	34
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	0	0	0	0	0	0
Deposits Assets	-	-	-	-	-	-	-	-	0	0	0	0
Other Assets
Deposits Assets Noncurrent	0	0	0	0	0	0	0	0	-	-	-	0
Deferred Costs	-	0	-	-	-	-	-	-	-	-	-	-
Goodwill	9	9	9	9	9	9	9	9	9	9	9	9
Other Assets	-	-	-	-	-	-	-	-	-	-	69	69
Other Assets Noncurrent	98	100	102	102	102	102	102	102	-	-	-	69
Assets	142	133	140	131	128	121	121	117	97	91	97	104
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	8	9	11	14	10	9	7	5	2	3	3	3
Accrued Liabilities Current	26	24	5	4	9	9	6	0	1	0	0	0
Employee Related Liabilities Current	2	4	3	3	4	3	3	2	2	1	2	2
Notes Payable Current	-	-	1	1	1	-	-	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	52	55	38	45	52	50	45	36	4	4	6	6
Deferred Income Tax Liabilities Net	8	8	8	8	8	7	7	7	7	6	6	6
Operating Lease Liability Noncurrent	1	1	1	1	1	1	-	0	0	0	0	0
Liabilities	66	63	47	53	60	58	52	43	11	11	12	12
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	344	330	327	306	296	283	277	271	276	259	256	253
Retained Earnings Accumulated Deficit	-277	-268	-247	-239	-231	-222	-211	-201	-191	-180	-171	-162
Stockholders Equity	76	69	93	78	65	61	65	70	86	80	85	91
Minority Interest	9	8	14	10	3	3	4	4	1	1	1	1
Liabilities And Stockholders Equity	142	133	140	131	128	121	121	117	97	91	97	104
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	250	250	250	16	16	16	400	400	400	16
Common Stock Shares Issued	27	22	22	18	14	9	8	7	7	6	6	6
Shares Outstanding	27	22	22	18	14	9	8	7	7	6	6	6

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	9.15%	11.63%	-8.50%	-20.00%	-17.86%	-18.57%	-	-	-	-	-	-
2025	-33.46%	-62.27%	-71.41%	-9.28%	135.61%	37.53%	-5.38%	5.38%	21.54%	-17.50%	-26.44%	-7.50%
2024	-3.24%	29.40%	-8.68%	-11.34%	-23.11%	31.83%	-23.30%	-37.19%	-48.05%	-10.33%	-26.90%	-59.24%
2023	-	-	-	-	-	-	-	-	-	-4.76%	5.02%	-2.77%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.84	0.58	0.99	0.62	0.47	0.37	0.41	0.40	6.75	5.17	5.06	5.95
Quick Ratio	0.34	0.10	0.31	0.09	0.12	0.00	0.02	0.09	4.31	3.01	3.65	4.58
Working Capital	-8.32M	-23.33M	-261.99K	-16.98M	-27.23M	-31.50M	-26.48M	-21.59M	23.85M	17.40M	22.63M	28.59M
Leverage & Debt
Debt to Equity	0.87	0.92	0.50	0.69	0.92	0.95	0.79	0.57	0.13	0.13	0.14	0.13
Interest Coverage TTM	-119.00	-128.06	-88.60	-143.87	-238.82	-	-	-	-	-	-	-
Debt Ratio	0.47	0.48	0.33	0.41	0.47	0.48	0.43	0.36	0.11	0.12	0.12	0.12
Efficiency & Turnover
Asset Turnover TTM	0.05	0.04	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding TTM	35.25	70.19	374.72	-	-	-	-	-	-	-	-	-
Receivables Turnover TTM	10.35	5.20	0.97	-	-	-	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-1.93	-2.12	-1.72	-3.38	-3.72	-5.02	-5.44	-5.97	-5.55	-5.69	-6.00	-5.38
Free Cash Flow Per Share TTM	-1.52	-1.64	-1.83	-2.40	-1.87	-2.74	-3.58	-4.19	-4.18	-4.76	-4.78	-4.80
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-863.92%	-1,041.44%	-950.92%	-	-	-	-	-	-	-	-	-
Net Profit Margin TTM	-710.80%	-844.25%	-939.62%	-	-	-	-	-	-	-	-	-
Growth Metrics
Net Income Growth (1Y)	23.21%	9.93%	-9.00%	-6.85%	6.15%	19.05%	6.66%	23.49%	26.23%	16.87%	36.31%	-3.26%
EPS Growth (1Y)	-48.18%	-57.84%	-68.28%	-43.37%	-32.93%	-11.72%	-9.49%	11.09%	11.65%	7.45%	25.39%	-6.60%
Valuation Metrics
P/E TTM	-0.31	-0.43	-0.45	-0.37	-0.43	-0.30	-0.74	-2.10	-2.63	-3.94	-3.15	-3.18
P/B TTM	0.21	0.29	0.18	0.18	0.27	0.21	0.46	1.14	1.18	1.78	1.42	1.13
P/S TTM	2.23	3.59	4.23	-	-	-	-	-	-	-	-	-
Market Cap	15.83M	20.14M	16.70M	13.72M	17.50M	12.79M	29.97M	84.26M	101.53M	142.69M	120.33M	103.49M
Enterprise Value	-1.17M	15.55M	9.98M	10.47M	12.41M	12.76M	28.87M	81.00M	83.62M	130.13M	99.98M	77.00M
Calculated Values
Free Cash Flow TTM	-39.87M	-36.60M	-39.24M	-26.55M	-20.58M	-23.55M	-26.79M	-28.20M	-29.09M	-30.30M	-30.37M	-29.06M
Net Debt	-17.01M	-4.59M	-6.72M	-3.25M	-5.09M	-26.41K	-1.10M	-3.25M	-17.91M	-12.56M	-20.35M	-26.48M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2019-09-27Purchase

Owner: Holubiak, Myron Z

Title: President and CEO

Shares: 558,597

Price/Share: $0.90

Value: $502,737.30

Shares Owned: 1,992,243

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2019-09-27Purchase

Owner: Mazur, Leonard L

Title: Executive Chairman

Shares: 2,234,700

Price/Share: $0.90

Value: $2,011,230.00

Shares Owned: 10,255,343

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2019-04-03Purchase

Owner: Holubiak, Myron Z

Title: President and CEO

Shares: 129,450

Price/Share: $1.55

Value: $200,647.50

Shares Owned: 1,433,646

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2019-04-03Purchase

Owner: Mazur, Leonard L

Title: Executive Chairman

Shares: 1,165,048

Price/Share: $1.55

Value: $1,805,824.40

Shares Owned: 8,020,643

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2018-08-13Purchase

Owner: Holubiak, Myron Z

Title: President and CEO

Shares: 784,314

Price/Share: $1.28

Value: $1,003,921.92

Shares Owned: 1,304,196

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2019-09-27	Holubiak, Myron Z	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	558,597	0.90	$502,737.30	1,992,243	4
2019-09-27	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	2,234,700	0.90	$2,011,230.00	10,255,343	4
2019-04-03	Holubiak, Myron Z	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	129,450	1.55	$200,647.50	1,433,646	4
2019-04-03	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	1,165,048	1.55	$1,805,824.40	8,020,643	4
2018-08-13	Holubiak, Myron Z	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	784,314	1.28	$1,003,921.92	1,304,196	4
2018-08-13	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	3,137,255	1.28	$4,015,686.40	6,855,595	4
2018-03-29	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	167,504	2.99	$500,836.96	3,718,340	4
2018-03-28	Holubiak, Myron Z	Director,Officer	President and CEO	Direct	Purchase	2,915	3.09	$9,007.35	519,882	4
2017-12-19	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	213,106	4.69	$999,467.14	3,550,836	4
2017-08-24	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	11,000	2.68	$29,480.00	3,337,730	4
2017-08-08	Mazur, Leonard L	Director,Officer,TenPercentOwner	Executive Chairman	Direct	Purchase	421,400	4.13	$1,740,382.00	1,779,663	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

4.18%

Inst. Shares: 936,128

Shares Outstanding: 22,376,427

2025-12-31

8.00%

Inst. Shares: 1,720,560

Shares Outstanding: 21,495,274

2025-09-30

5.40%

Inst. Shares: 597,744

Shares Outstanding: 11,065,225

2025-06-30

6.77%

Inst. Shares: 745,136

Shares Outstanding: 11,006,896

2025-03-31

7.39%

Inst. Shares: 634,508

Shares Outstanding: 8,581,207

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	936,128	22,376,427	4.18%
2025-12-31	1,720,560	21,495,274	8.00%
2025-09-30	597,744	11,065,225	5.40%
2025-06-30	745,136	11,006,896	6.77%
2025-03-31	634,508	8,581,207	7.39%
2024-12-31	679,605	7,492,460	9.07%
2024-09-30	23,423,575	6,726,999	-
2024-06-30	30,180,011	6,954,278	-
2024-03-31	26,636,011	6,362,890	-
2023-12-31	26,374,524	6,358,237	-
2023-09-30	24,187,642	6,051,789	-
2023-06-30	24,267,270	6,151,015	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Citius Pharmaceuticals, Inc. (CTXR) — SEC Financial Statements & Analysis

Citius Pharmaceuticals, Inc. (CTXR) is a pharmaceutical preparations company, incorporated in NV. Citius Pharmaceuticals, Inc. trades on Nasdaq as: CTXR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Citius Pharmaceuticals, Inc. reported a Debt-to-Equity ratio of 0.87x, a Price-to-Sales (P/S) ratio of 2.23x (TTM), a Price-to-Book (P/B) ratio of 0.21x (TTM), at a market cap of $15.83M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.87x
P/S TTM: 2.23x
P/B TTM: 0.21x
Market Cap: $15.83M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Citius Pharmaceuticals, Inc. in?

Citius Pharmaceuticals, Inc. (CTXR) operates in the Pharmaceutical Preparations industry.

What is CTXR's market cap?

Citius Pharmaceuticals, Inc. (CTXR) has a market capitalization of $15.83M as of 2026-06-30.

What exchange does CTXR trade on?

Citius Pharmaceuticals, Inc. (CTXR) trades on the Nasdaq.

Where is Citius Pharmaceuticals, Inc. incorporated?

Citius Pharmaceuticals, Inc. is incorporated in NV.